Skip to content

MEBEMED

Active Private limited companyfounded 2004active for 22 yearsLouis Schmidtlaan 28A, 1040 EtterbeekKBO/BCE: BE 0866.145.167

Lifetime

16 annual accounts with figures on one time axis, 18 filings since 2005
peak of €74,964 in 2019
€4,283▲ €8,639
lowest -€33,302 in 2024
-€3,590▲ €29,711
peak of €47,934 in 2022
-€13,404▼ €3,590
€26,044▲ 54.1%
Board2 names since 2022
2 directors and 1 other
Documentsfilings and deeds
21-02-202621 days late
2025micro format
Gross margin from -€4,356 to €4,283Loss of €3,590Equity from -€9,814 to -€13,404Debts from €16,897 to €26,044

Key points

from the 2025 annual accounts

Equity

-€13,404
201920212022202320242025

Debts exceed assets in financial year 2025.

Losses

-€61,338 in three years
-24,4462023-33,3022024-3,5902025

Every financial year from 2023 to 2025 closed with a loss. 2024 was the heaviest.

Turnover

≈ €26,000 estimated

The micro format states no turnover.

Debts

€26,044 206% of the balance sheet
Suppliers 20%Taxes and wages 3%Other 76%

Filings

18 annual accounts since 2005
deadline20052010201520202025

Nine of the last ten came late. The 2015 accounts came in latest, 29 days after the end of the period.

Position in the sector

-106.0%

Lower solvency than 95% of companies in human health. The sector median is 63.1%, over 21,373 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,641 companies had the same profile as MEBEMED has now. Each dot stands for 17 companies, two years later.

84.2%
were still trading
10.3%
stopped another way
4.5%
went bankrupt
  • Micro
  • 20 years or older
  • negative equity
  • a loss of 10% of the balance sheet or more

Another 1.0% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,641 companies, not a prediction for MEBEMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0866145167
(director) and (director) change roles Discharge granted to · Discharge granted to · General meeting of 20-12-2023 · Gazette deed
Incorporation published on 13-07-2004 · Gazette deed
All 27 events

Comparable companies

same main activity, similar in size and age
Company
MEBEMED Etterbeek €12,640 €4,283 -106.0% -
THEOMED Auderghem €33,969 €4,934 46.9% -
SCOTALIX Ghent €22,930 €5,575 48.9% -
BRUSSEL'S UROLOGICAL SOCIETY Uccle €32,290 €7,142 83.9% -
Dell' Aquila Vincent La Louvière €4,603 €2,285 -375.5% -
RUMAN Nivelles €38,692 €2,500 -930.0% -
VDSCURE Ittre €4,605 €4,174 -22.7% -

These companies have the same main activity as MEBEMED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €4,600 and €38,700, founded between 1983 and 2019.

Official details

Source: KBO
Status
Active since 05-07-2004Normal situation
Activity
General medical practiceNACE 86210
Financial year end
30 June
Peppol
Reachable since 14-11-2025
Company details

Annual accounts to 30-06-2025

€12,640▲ 78.4%
Filing
Filed on 21-02-2026
Financials

Insights on MEBEMED

MEBEMED files the micro format. That format states no turnover. The gross margin fell from €22,101 in 2007 to €4,283 in 2025.

The balance sheet grew most from 2016 to 2017 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEBEMED

What is the company number of MEBEMED?
The company number of MEBEMED is 0866.145.167. The VAT number is the same number with BE in front: BE 0866.145.167.
Where is MEBEMED based?
The registered office is at Louis Schmidtlaan 28A, 1040 Etterbeek.Company details
What does MEBEMED do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of MEBEMED?
MEBEMED is a private limited company (BV).
When was MEBEMED founded?
MEBEMED was founded on 05-07-2004.
Is MEBEMED still active?
Yes, MEBEMED is an active enterprise in the KBO register.
What is the turnover of MEBEMED?
The turnover in financial year 2025 is about €26,000. This figure is estimated from the gross margin of €4,283 and 52 comparable companies (NACE 86). It probably lies between €18,000 and €46,000. It is a rough estimate.Financials
Is MEBEMED profitable?
In financial year 2025, MEBEMED made a loss of €3,590.
Where can I find the annual accounts of MEBEMED?
MEBEMED filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEBEMED due?
MEBEMED must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.